These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 10471581)
1. Influence of cefodizime on pulmonary inflammatory response to heat-killed Klebsiella pneumoniae in mice. Bergeron Y; Deslauriers AM; Ouellet N; Gauthier MC; Bergeron MG Antimicrob Agents Chemother; 1999 Sep; 43(9):2291-4. PubMed ID: 10471581 [TBL] [Abstract][Full Text] [Related]
2. Reduction by cefodizime of the pulmonary inflammatory response induced by heat-killed Streptococcus pneumoniae in mice. Bergeron Y; Ouellet N; Deslauriers AM; Simard M; Olivier M; Bergeron MG Antimicrob Agents Chemother; 1998 Oct; 42(10):2527-33. PubMed ID: 9756751 [TBL] [Abstract][Full Text] [Related]
3. Decrease in surface charge density of Klebsiella pneumoniae treated with cefodizime and enhancement of the phagocytic function of human polymorphonuclear leucocytes stimulated by the drug-treated bacteria. Muratsugu M; Miyake Y; Ishida N; Hyodo A; Terayama K Biol Pharm Bull; 1995 Sep; 18(9):1259-63. PubMed ID: 8845818 [TBL] [Abstract][Full Text] [Related]
4. Thalidomide treatment modulates macrophage pro-inflammatory function and cytokine levels in Klebsiella pneumoniae B5055 induced pneumonia in BALB/c mice. Kumar V; Harjai K; Chhibber S Int Immunopharmacol; 2010 Jul; 10(7):777-83. PubMed ID: 20399910 [TBL] [Abstract][Full Text] [Related]
6. Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae. Tsai WC; Strieter RM; Zisman DA; Wilkowski JM; Bucknell KA; Chen GH; Standiford TJ Infect Immun; 1997 May; 65(5):1870-5. PubMed ID: 9125574 [TBL] [Abstract][Full Text] [Related]
7. Immunomodulating effects of HMR 3004 on pulmonary inflammation caused by heat-killed Streptococcus pneumoniae in mice. Duong M; Simard M; Bergeron Y; Ouellet N; Côté-Richer M; Bergeron MG Antimicrob Agents Chemother; 1998 Dec; 42(12):3309-12. PubMed ID: 9835535 [TBL] [Abstract][Full Text] [Related]
8. Cefquinome-Loaded Microsphere Formulations in Protection against Pneumonia with Klebsiella pneumonia Infection and Inflammatory Response in Rats. Qu S; Dai C; Yang F; Huang T; Hao Z; Tang Q; Wang H; Zhang Y Pharm Res; 2019 Mar; 36(5):74. PubMed ID: 30923922 [TBL] [Abstract][Full Text] [Related]
9. The IκB family member Bcl-3 coordinates the pulmonary defense against Klebsiella pneumoniae infection. Pène F; Paun A; Sønder SU; Rikhi N; Wang H; Claudio E; Siebenlist U J Immunol; 2011 Feb; 186(4):2412-21. PubMed ID: 21228348 [TBL] [Abstract][Full Text] [Related]
10. Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival. Broug-Holub E; Toews GB; van Iwaarden JF; Strieter RM; Kunkel SL; Paine R; Standiford TJ Infect Immun; 1997 Apr; 65(4):1139-46. PubMed ID: 9119443 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime. Nomura S; Nagayama A Chemotherapy; 1995; 41(4):267-75. PubMed ID: 7555207 [TBL] [Abstract][Full Text] [Related]
12. Caspase-11 deficiency impairs neutrophil recruitment and bacterial clearance in the early stage of pulmonary Klebsiella pneumoniae infection. Wang J; Shao Y; Wang W; Li S; Xin N; Xie F; Zhao C Int J Med Microbiol; 2017 Dec; 307(8):490-496. PubMed ID: 28939441 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime. Nomura S; Nagayama A Chemotherapy; 1995; 41(3):178-86. PubMed ID: 7656663 [TBL] [Abstract][Full Text] [Related]
14. Macrophage inflammatory protein 1alpha/CCL3 is required for clearance of an acute Klebsiella pneumoniae pulmonary infection. Lindell DM; Standiford TJ; Mancuso P; Leshen ZJ; Huffnagle GB Infect Immun; 2001 Oct; 69(10):6364-9. PubMed ID: 11553580 [TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effects of inhaled nitric oxide are optimized at lower oxygen concentration in experimental Klebsiella pneumoniae pneumonia. Sun Z; Sun B; Wang X; Wang W; Zhu L Inflamm Res; 2006 Oct; 55(10):430-40. PubMed ID: 17109070 [TBL] [Abstract][Full Text] [Related]
16. Binding of complement C3 to Klebsiella pneumoniae treated with sub-MIC cefodizime and chemiluminescence response of human polymorphonuclear leukocytes. Nomura S; Kuroiwa A; Murata K; Nagayama A Chemotherapy; 1997; 43(2):132-6. PubMed ID: 9084922 [TBL] [Abstract][Full Text] [Related]
17. Preliminary investigation of a mice model of Klebsiella pneumoniae subsp. ozaenae induced pneumonia. Renois F; Jacques J; Guillard T; Moret H; Pluot M; Andreoletti L; de Champs C Microbes Infect; 2011 Nov; 13(12-13):1045-51. PubMed ID: 21723409 [TBL] [Abstract][Full Text] [Related]
18. Comparative effects of cefpirome (HR 810) and other cephalosporins on experimentally induced pneumonia in mice. Klesel N; Isert D; Limbert M; Seibert G; Winkler I; Schrinner E J Antibiot (Tokyo); 1986 Jul; 39(7):971-7. PubMed ID: 3531131 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Ye P; Garvey PB; Zhang P; Nelson S; Bagby G; Summer WR; Schwarzenberger P; Shellito JE; Kolls JK Am J Respir Cell Mol Biol; 2001 Sep; 25(3):335-40. PubMed ID: 11588011 [TBL] [Abstract][Full Text] [Related]